NO930739L - Substituerte fenylkinazolinderivater - Google Patents

Substituerte fenylkinazolinderivater

Info

Publication number
NO930739L
NO930739L NO93930739A NO930739A NO930739L NO 930739 L NO930739 L NO 930739L NO 93930739 A NO93930739 A NO 93930739A NO 930739 A NO930739 A NO 930739A NO 930739 L NO930739 L NO 930739L
Authority
NO
Norway
Prior art keywords
hydrogen
alkyl
alkoxy
trifluoromethyl
substituted phenyl
Prior art date
Application number
NO93930739A
Other languages
English (en)
Norwegian (no)
Other versions
NO930739D0 (no
Inventor
Paul Leroy Anderson
William Joseph Houlihan
Prasad Koteswara Kapa
Andrew Kucerovy
Paul Gerard Mattner
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO930739D0 publication Critical patent/NO930739D0/no
Publication of NO930739L publication Critical patent/NO930739L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO93930739A 1992-03-03 1993-03-01 Substituerte fenylkinazolinderivater NO930739L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84512392A 1992-03-03 1992-03-03

Publications (2)

Publication Number Publication Date
NO930739D0 NO930739D0 (no) 1993-03-01
NO930739L true NO930739L (no) 1993-09-06

Family

ID=25294463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930739A NO930739L (no) 1992-03-03 1993-03-01 Substituerte fenylkinazolinderivater

Country Status (14)

Country Link
EP (1) EP0564397A1 (zh)
JP (1) JPH0649076A (zh)
KR (1) KR930019642A (zh)
CN (1) CN1076445A (zh)
AU (1) AU3387593A (zh)
CA (1) CA2090635A1 (zh)
CZ (1) CZ30293A3 (zh)
FI (1) FI930922A (zh)
HU (1) HUT63629A (zh)
IL (1) IL104892A0 (zh)
NO (1) NO930739L (zh)
NZ (1) NZ247032A (zh)
TW (1) TW227563B (zh)
ZA (1) ZA931516B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655289A1 (en) * 2004-11-04 2006-05-10 Embl Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives
CA2838765C (en) * 2011-06-10 2019-05-07 Chiesi Farmaceutici S.P.A. Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CN104119231A (zh) * 2013-04-27 2014-10-29 重庆华邦制药有限公司 二苯甲胺类化合物的制备方法及中间体
US9834525B2 (en) 2014-02-04 2017-12-05 University Of Tennessee Research Foundation Inhibitors of paxillin function and related compositions and methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242863A (en) * 1968-05-10 1971-08-18 Pharmacia As 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF
DE3734909A1 (de) * 1987-10-15 1989-04-27 Boehringer Ingelheim Kg Verwendung von oxochinazolinderivaten bei der behandlung der hyperlipidaemie

Also Published As

Publication number Publication date
HUT63629A (en) 1993-09-28
AU3387593A (en) 1993-09-09
KR930019642A (ko) 1993-10-18
CA2090635A1 (en) 1993-09-04
JPH0649076A (ja) 1994-02-22
FI930922A (fi) 1993-09-04
ZA931516B (en) 1994-09-03
HU9300556D0 (en) 1993-05-28
CZ30293A3 (en) 1993-12-15
CN1076445A (zh) 1993-09-22
TW227563B (zh) 1994-08-01
FI930922A0 (fi) 1993-03-02
EP0564397A1 (en) 1993-10-06
NO930739D0 (no) 1993-03-01
IL104892A0 (en) 1993-07-08
NZ247032A (en) 1994-11-25

Similar Documents

Publication Publication Date Title
NO940563D0 (no) Substituerte benzoylquanidiner, fremgangsmåter for fremstilling av dem, deres anvendelse som medikament eller diagnostikum, samt medikamenter inneholdende dem
NO952854L (no) 1-arylpyrimidin-derivater
FR2396749A1 (fr) Analogues de prostacycline
SE8302464L (sv) Aromatiskt alkanderivat samt sett for framstellning derav
NO167088C (no) Nye 5-alkoxy-2,4 diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen.
NO930739L (no) Substituerte fenylkinazolinderivater
NO964053L (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
MY101880A (en) Benzoylphenylureas, the preparation thereof and the use thereof in pest control.
BR8504542A (pt) Processo para preparar um composto,aplicacao de tal composto,processo para combater insetos e representantes da ordem acarina,bem como composicao praguicida
ES8505975A1 (es) Procedimiento para la produccion de s,s-dioxidos de 3-acilamino-benzoisotiazol
IE890514L (en) Therapeutic agents for the treatment of peptic ulcer disease
DK287282A (da) Fremgangsmaade til fremstilling af adamantylethylaminer
MX9204457A (es) Compuestos de 6-oxo-azepinoidol, asi como procedimientos y productos intermedios para su preparacion, y medicamentos que contienen estos compuestos.
DE3788149D1 (de) Prostazyklin-(PGI2)-Analoge.
IE40727L (en) Aralkylamines
MX9602841A (es) Benzoilguanidinas sustituidas con fluoroalquilo en la posicion 4, un procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como un medicamento que las contiene.
DK455285A (da) 2-pyridin-thiolderivater
DE3783817D1 (de) Mikrobizide mittel.
ES8304111A1 (es) Procedimiento para la preparacion de 2,3-dihidro piranos.
SE9401965D0 (sv) New compounds
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
FR2417985A1 (fr) Nouvelle association medicamenteuse a base d'un derive de la dibenzo(b,e) (1,4)diazepine-11-one
DK0455899T3 (da) Prostaglandin I-analog
CA2016300A1 (en) Prostaglandin i analogue